Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 22, Pages 5616
Publisher
MDPI AG
Online
2019-11-12
DOI
10.3390/ijms20225616
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling
- (2019) Maja Kim Kuepper et al. LEUKEMIA
- Current Outlook on Autophagy in Human Leukemia: Foe in Cancer Stem Cells and Drug Resistance, Friend in New Therapeutic Interventions
- (2019) Katharina Rothe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells
- (2019) Puneet Agarwal et al. Cell Stem Cell
- Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study
- (2019) Aytug Kizilors et al. Lancet Haematology
- Combined inhibition of MDM2 and Bcr-Abl tyrosine kinase targets chronic myeloid leukemia stem/progenitor cells in a murine model
- (2019) Bing Z. Carter et al. HAEMATOLOGICA
- Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway
- (2019) Xiaoyan Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SIRT1 regulates metabolism and leukemogenic potential in CML stem cells
- (2019) Ajay Abraham et al. JOURNAL OF CLINICAL INVESTIGATION
- Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants
- (2019) Christopher A. Eide et al. CANCER CELL
- Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress
- (2018) Jiaqiao Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21
- (2018) Ziye Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Overexpression of miR-202 resensitizes imatinib resistant chronic myeloid leukemia cells through targetting Hexokinase 2
- (2018) Yingjun Deng et al. BIOSCIENCE REPORTS
- Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high risk disease
- (2018) Susan Branford et al. BLOOD
- Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph + chronic myeloid leukemia
- (2018) Michael Willmann et al. EXPERIMENTAL HEMATOLOGY
- Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML
- (2018) Oscar Brück et al. LEUKEMIA
- Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy
- (2018) Simona Soverini et al. Molecular Cancer
- DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+ CD15− cells in early chronic-phase chronic myeloid leukemia
- (2018) Stéphanie Maupetit-Mehouas et al. Molecular Oncology
- Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia
- (2018) Bin Zhang et al. NATURE MEDICINE
- Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial
- (2018) Maro Ohanian et al. Lancet Haematology
- Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
- (2018) Joseph Schoepfer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting quiescent leukemic stem cells using second generation autophagy inhibitors
- (2018) Pablo Baquero et al. LEUKEMIA
- Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
- (2018) Courtney L. Jones et al. CANCER CELL
- A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease
- (2018) Kendra Sweet et al. LEUKEMIA RESEARCH
- Preclinical approaches in chronic myeloid leukemia: from cells to systems
- (2017) Cassie J. Clarke et al. EXPERIMENTAL HEMATOLOGY
- Long noncoding RNA HULC promotes cell proliferation by regulating PI3K/AKT signaling pathway in chronic myeloid leukemia
- (2017) Yinghao Lu et al. GENE
- Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
- (2017) Rebecca Mitchell et al. JNCI-Journal of the National Cancer Institute
- Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo
- (2017) H Zhou et al. LEUKEMIA
- Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia
- (2017) Ayuna Hattori et al. NATURE
- Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
- (2017) Elodie M Kuntz et al. NATURE MEDICINE
- Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia
- (2017) Alice Giustacchini et al. NATURE MEDICINE
- Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells
- (2017) H S Madapura et al. ONCOGENE
- Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options
- (2017) Steffen Koschmieder et al. SEMINARS IN CANCER BIOLOGY
- Ovatodiolide targets chronic myeloid leukemia stem cells by epigenetically upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3K/AKT/mTOR pathway
- (2017) Yue-Xing Tu et al. Oncotarget
- Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells
- (2017) Simona Salati et al. Oncotarget
- Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence
- (2017) Angela Ianniciello et al. Oncotarget
- Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
- (2017) Rebecca Mitchell et al. JNCI-Journal of the National Cancer Institute
- The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia
- (2017) Muhammad Rauzan et al. PLoS One
- Mammalian Autophagy: How Does It Work?
- (2016) Carla F. Bento et al. Annual Review of Biochemistry
- ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells
- (2016) Maria Karvela et al. Autophagy
- Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function
- (2016) Meifang Xiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk/Mnk1/eIF4E pathway
- (2016) Zhong Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI
- (2016) Puneet Agarwal et al. BLOOD
- CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression
- (2016) Anuradha Tarafdar et al. BLOOD
- Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer
- (2016) Q. Dou et al. CANCER RESEARCH
- Novel oral transforming growth factor-β signaling inhibitor EW-7197 eradicates CML-initiating cells
- (2016) Kazuhito Naka et al. CANCER SCIENCE
- Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche
- (2016) Haobin Ye et al. Cell Stem Cell
- Gas6/AXL Signaling Regulates Self-Renewal of Chronic Myelogenous Leukemia Stem Cells by Stabilizing β-Catenin
- (2016) Yanli Jin et al. CLINICAL CANCER RESEARCH
- Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia
- (2016) Yanli Jin et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolite Profiling of the Plasma and Leukocytes of Chronic Myeloid Leukemia Patients
- (2016) Radana Karlíková et al. JOURNAL OF PROTEOME RESEARCH
- Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells
- (2016) Sheela A. Abraham et al. NATURE
- Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells
- (2016) Bing Z. Carter et al. Science Translational Medicine
- Potential role of Wnt/β-catenin signaling in blastic transformation of chronic myeloid leukemia: cross talk between β-catenin and BCR-ABL
- (2016) Jing Hu et al. TUMOR BIOLOGY
- PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
- (2016) E Glodkowska-Mrowka et al. Blood Cancer Journal
- Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition
- (2016) M. T. Scott et al. Cancer Discovery
- Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2
- (2016) H. Xie et al. Cancer Discovery
- BM microenvironmental protection of CML cells from imatinib through Stat5/NF-κB signaling and reversal by Wogonin
- (2016) Xuefen Xu et al. Oncotarget
- Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia
- (2016) David A. Irvine et al. Scientific Reports
- Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
- (2016) Lauren Caldemeyer et al. Current Hematologic Malignancy Reports
- Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang
- (2016) Hong-Sheng Zhou et al. Cancer Biology & Medicine
- Chronic Myeloid Leukemia - Prognostic Value of Mutations
- (2015) Bushra Kaleem et al. Asian Pacific Journal of Cancer Prevention
- Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia
- (2015) Xian Zeng et al. Autophagy
- Treatment of Chronic Myelogenous Leukemia by Blocking Cytokine Alterations Found in Normal Stem and Progenitor Cells
- (2015) Robert S. Welner et al. CANCER CELL
- Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities
- (2015) Koen Schepers et al. Cell Stem Cell
- miRNAs as Biomarkers in Chronic Myelogenous Leukemia
- (2015) Kasuen Kotagama et al. DRUG DEVELOPMENT RESEARCH
- The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells
- (2015) L Mourgues et al. LEUKEMIA
- Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells
- (2015) C Riether et al. LEUKEMIA
- BCL2 gene polymorphisms and splicing variants in chronic myeloid leukemia
- (2015) Vicent Guillem et al. LEUKEMIA RESEARCH
- Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists
- (2015) Stéphane Prost et al. NATURE
- Tyrosine kinase inhibitor–induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling
- (2015) Carsten Riether et al. Science Translational Medicine
- Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells
- (2015) Bing Z. Carter et al. Oncotarget
- Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study
- (2015) Giovanni Martinelli et al. Lancet Haematology
- Selective JAK2/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem/progenitor cells
- (2015) Hanyang Lin et al. Oncotarget
- The BCL2 inhibitor ABT-199 significantly enhances imatinib-induced cell death in chronic myeloid leukemia progenitors
- (2015) Tun Kiat Ko et al. Oncotarget
- DNA Hypermethylation of Cell Cycle (p15 and p16) and Apoptotic (p14, p53, DAPK and TMS1) Genes in Peripheral Blood of Leukemia Patients
- (2014) Khaldon Bodoor et al. Asian Pacific Journal of Cancer Prevention
- Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche
- (2014) D. S. Krause et al. BLOOD
- JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo
- (2014) P. Gallipoli et al. BLOOD
- Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia
- (2014) H. Herrmann et al. BLOOD
- Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition
- (2014) K. P. Ng et al. BLOOD
- MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors
- (2014) L.-S. Wang et al. BLOOD
- The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells
- (2014) K. Rothe et al. BLOOD
- BMI1 gene expression in myeloid leukemias and its impact on prognosis
- (2014) Niveen S. Saudy et al. BLOOD CELLS MOLECULES AND DISEASES
- BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
- (2014) Matthew S. Zabriskie et al. CANCER CELL
- Chromatin Repressive Complexes in Stem Cells, Development, and Cancer
- (2014) Anne Laugesen et al. Cell Stem Cell
- Epigenetic Silencing of P16 (INK4a) Gene by Promoter Hypermethylation in Chronic Myelogenous Leukemia
- (2014) Imtiyaz Ahmad et al. Clinical Lymphoma Myeloma & Leukemia
- Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia
- (2014) SHAN SHAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival
- (2014) Yaoyu Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Studies on microRNAs that are correlated with the cancer stem cells in chronic myeloid leukemia
- (2014) Xishan Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML In Vitro and In Vivo
- (2014) K. Beider et al. MOLECULAR CANCER THERAPEUTICS
- A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA
- (2014) G Guo et al. ONCOGENE
- A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
- (2014) J F Seymour et al. Blood Cancer Journal
- IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia
- (2014) Mette Ilander et al. OncoImmunology
- Primitive CML cell expansion relies on abnormal levels of BMPs provided by the niche and on BMPRIb overexpression
- (2013) B. Laperrousaz et al. BLOOD
- Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt- -catenin signaling
- (2013) B. Zhang et al. BLOOD
- A Pan-BCL2 Inhibitor Renders Bone-Marrow-Resident Human Leukemia Stem Cells Sensitive to Tyrosine Kinase Inhibition
- (2013) Daniel J. Goff et al. Cell Stem Cell
- Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche
- (2013) Koen Schepers et al. Cell Stem Cell
- BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
- (2013) Eleni D. Lagadinou et al. Cell Stem Cell
- Combination of Ponatinib with Hedgehog Antagonist Vismodegib for Therapy-Resistant BCR-ABL1-Positive Leukemia
- (2013) S. Katagiri et al. CLINICAL CANCER RESEARCH
- The Methylation Status of the DDX43 Promoter in Chinese Patients with Chronic Myeloid Leukemia
- (2013) Qin Chen et al. Genetic Testing and Molecular Biomarkers
- Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+CML stem/progenitor cells
- (2013) Sadegh Babashah et al. INTERNATIONAL JOURNAL OF CANCER
- Gene regulation by antisense transcription
- (2013) Vicent Pelechano et al. NATURE REVIEWS GENETICS
- Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
- (2013) Lisa Christiansson et al. PLoS One
- Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate
- (2013) Yajuan Li et al. PLoS One
- Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function
- (2013) S. Lim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia
- (2013) J Menezes et al. Blood Cancer Journal
- Targeting of GSK3 promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells
- (2012) G. Reddiconto et al. BLOOD
- HIF1 is required for survival maintenance of chronic myeloid leukemia stem cells
- (2012) H. Zhang et al. BLOOD
- Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib
- (2012) Ling Li et al. CANCER CELL
- Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia
- (2012) Bin Zhang et al. CANCER CELL
- Epigenetic Therapy With Hydralazine and Magnesium Valproate Reverses Imatinib Resistance in Patients With Chronic Myeloid Leukemia
- (2012) Eduardo Cervera et al. Clinical Lymphoma Myeloma & Leukemia
- ABT-737 increases tyrosine kinase inhibitor–induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34+ CD38− population to imatinib
- (2012) Kelly Airiau et al. EXPERIMENTAL HEMATOLOGY
- CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression
- (2012) Christian Schürch et al. JOURNAL OF CLINICAL INVESTIGATION
- MK-0457, an Aurora kinase and BCR–ABL inhibitor, is active in patients with BCR–ABL T315I leukemia
- (2012) F J Giles et al. LEUKEMIA
- Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells
- (2012) Y Yu et al. LEUKEMIA
- SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells
- (2012) Z Wang et al. ONCOGENE
- Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis
- (2011) H. Yuan et al. BLOOD
- Combination of pegylated IFN- 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
- (2011) B. Simonsson et al. BLOOD
- BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription
- (2011) Z. Sheng et al. BLOOD
- Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
- (2011) A. Hamilton et al. BLOOD
- Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML
- (2011) G. V. Helgason et al. BLOOD
- Quantitative and functional analyses of CD4+CD25+FoxP3+ regulatory T cells in chronic phase chronic myeloid leukaemia patients at diagnosis and on imatinib mesylate
- (2011) Emmanuel Bachy et al. BRITISH JOURNAL OF HAEMATOLOGY
- IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development
- (2011) Damien Reynaud et al. CANCER CELL
- Molecular Pathways: BCR-ABL
- (2011) D. Cilloni et al. CLINICAL CANCER RESEARCH
- BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
- (2011) Christian Hurtz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Activation of apoptosis signaling eliminates CD34+ progenitor cells in blast crisis CML independent of response to tyrosine kinase inhibitors
- (2011) D H Mak et al. LEUKEMIA
- The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem/progenitor cells
- (2011) F Pellicano et al. LEUKEMIA
- Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib
- (2011) E Weisberg et al. LEUKEMIA
- Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors
- (2011) Bruno Calabretta et al. LEUKEMIA & LYMPHOMA
- Expression patterns of microRNAs associated with CML phases and their disease related targets
- (2011) Kateřina Machová Poláková et al. Molecular Cancer
- Aberrant DNA Methylation Is Associated with Disease Progression, Resistance to Imatinib and Shortened Survival in Chronic Myelogenous Leukemia
- (2011) Jaroslav Jelinek et al. PLoS One
- BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells
- (2010) A. Rizo et al. BLOOD
- Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate
- (2010) Bin Zhang et al. CANCER CELL
- Wnt/Ca2+/NFAT Signaling Maintains Survival of Ph+ Leukemia Cells upon Inhibition of Bcr-Abl
- (2010) Mark A. Gregory et al. CANCER CELL
- Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation
- (2010) A. Puissant et al. CANCER RESEARCH
- Methylation patterns in CD34 positive chronic myeloid leukemia blast crisis cells
- (2010) J. J. W. M. Janssen et al. HAEMATOLOGICA
- Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia
- (2010) S. Flamant et al. HAEMATOLOGICA
- Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis
- (2010) F. Vianello et al. HAEMATOLOGICA
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
- (2010) Amie S. Corbin et al. JOURNAL OF CLINICAL INVESTIGATION
- Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid Leukemia
- (2010) Andreas Burchert et al. JOURNAL OF CLINICAL ONCOLOGY
- Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
- (2010) François-Xavier Mahon et al. LANCET ONCOLOGY
- Janus kinase 2 regulates Bcr–Abl signaling in chronic myeloid leukemia
- (2010) A Samanta et al. LEUKEMIA
- Inhibition of Grb2 expression demonstrates an important role in BCR–ABL-mediated MAPK activation and transformation of primary human hematopoietic cells
- (2010) H Modi et al. LEUKEMIA
- High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression
- (2010) J Boultwood et al. LEUKEMIA
- TGF-β–FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
- (2010) Kazuhito Naka et al. NATURE
- Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
- (2010) Claude Preudhomme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Myeloid Leukemia Patients Sensitive and Resistant to Imatinib Treatment Show Different Metabolic Responses
- (2010) Jiye A et al. PLoS One
- Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients
- (2010) YOUNGIL KOH et al. Oncology Letters
- Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia
- (2009) D. H. Kim et al. BLOOD
- Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia
- (2009) D. Milojkovic et al. CLINICAL CANCER RESEARCH
- Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia
- (2009) Edurne San José-Eneriz et al. EUROPEAN JOURNAL OF CANCER
- Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells
- (2009) Cristian Bellodi et al. JOURNAL OF CLINICAL INVESTIGATION
- Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+cell to Imatinib and Nilotinib
- (2009) Falk Dillmann et al. LEUKEMIA & LYMPHOMA
- sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia
- (2009) Melek Pehlivan et al. LEUKEMIA RESEARCH
- MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations
- (2009) Edurne San José-Enériz et al. Molecular Cancer
- Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
- (2009) Chen Zhao et al. NATURE
- Mechanisms of Polycomb gene silencing: knowns and unknowns
- (2009) Jeffrey A. Simon et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia
- (2008) Jun Qian et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Hypoxia regulates TSC1/2 mTOR signaling and tumor suppression through REDD1-mediated 14 3 3 shuttling
- (2008) M. P. DeYoung et al. GENES & DEVELOPMENT
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy
- (2008) J A McCubrey et al. LEUKEMIA
- β-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia
- (2008) Y Hu et al. LEUKEMIA
- Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth
- (2008) X. Agirre et al. MOLECULAR CANCER RESEARCH
- FOXOs, cancer and regulation of apoptosis
- (2008) Z Fu et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now